Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
D000166:Acridines / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D007942:Leukemia, Experimental / Q000188:drug therapy*; D009564:Nitracrine / Q000494:pharmacology* / Q000627:therapeutic use; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D000166:Acridines; D000970:Antineoplastic Agents; D009564:Nitracrine